| Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia Z Freyberg, D Aslanoglou, R Shah, JS Ballon Frontiers in neuroscience 11, 277892, 2017 | 79 | 2017 |
| New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion ZJ Farino, TJ Morgenstern, A Maffei, M Quick, AJ De Solis, ... Molecular psychiatry 25 (9), 2070-2085, 2020 | 69 | 2020 |
| Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors D Aslanoglou, S Bertera, M Sánchez-Soto, R Benjamin Free, J Lee, ... Translational psychiatry 11 (1), 59, 2021 | 62 | 2021 |
| Ribosome-associated vesicles: A dynamic subcompartment of the endoplasmic reticulum in secretory cells SD Carter, CM Hampton, R Langlois, R Melero, ZJ Farino, MJ Calderon, ... Science advances 6 (14), eaay9572, 2020 | 47 | 2020 |
| Gq/11-dependent regulation of endosomal cAMP generation by parathyroid hormone class B GPCR AD White, FG Jean-Alphonse, F Fang, KA Peña, S Liu, GM König, A Inoue, ... Proceedings of the National Academy of Sciences 117 (13), 7455-7460, 2020 | 37 | 2020 |
| Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age‐related neurodegeneration SA Buck, T Steinkellner, D Aslanoglou, M Villeneuve, SH Bhatte, ... Aging cell 20 (5), e13365, 2021 | 27 | 2021 |
| Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms H Wei, RC Zapata, M Lopez-Valencia, D Aslanoglou, ZJ Farino, V Benner, ... Psychoneuroendocrinology 113, 104551, 2020 | 24 | 2020 |
| Distinct agonist regulation of muscarinic acetylcholine M2-M3 heteromers and their corresponding homomers D Aslanoglou, E Alvarez-Curto, S Marsango, G Milligan Journal of Biological Chemistry 290 (23), 14785-14796, 2015 | 12 | 2015 |
| Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine D Aslanoglou, S Bertera, L Friggeri, M Sánchez-Soto, J Lee, X Xue, ... Iscience 25 (8), 2022 | 6 | 2022 |
| Homogeneous time-resolved förster resonance energy transfer-based assay for detection of insulin secretion D Aslanoglou, EW George, Z Freyberg JoVE (Journal of Visualized Experiments), e57531, 2018 | 6 | 2018 |
| Development of Melanocortin 4 Receptor Agonists by Exploiting Animal-Derived Macrocyclic, Disulfide-Rich Peptide Scaffolds E Muratspahić, D Aslanoglou, AM White, C Draxler, X Kozisek, Z Farooq, ... ACS Pharmacology & Translational Science 6 (10), 1373-1381, 2023 | 2 | 2023 |
| VGLUT modulates sex differences in dopamine neuron vulnerability to age-related neurodegeneration SA Buck, T Steinkellner, D Aslanoglou, M Villeneuve, SH Bhatte, ... bioRxiv, 2020.11. 11.379008, 2020 | 1 | 2020 |
| Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia A Bonifazi, M Ellenberger, ZJ Farino, D Aslanoglou, R Rais, S Pereira, ... bioRxiv, 2024.02. 21.581451, 2024 | | 2024 |
| Dual pancreatic adrenergic and dopaminergic signalling as a therapeutic target of bromocriptine D Aslanoglou, S Bertera, M Sanchez-Soto, B Free, R Lane, L Friggeri, ... BRITISH JOURNAL OF PHARMACOLOGY 180 (4), 508-509, 2023 | | 2023 |
| 1299-P: Novel Tools to Dissect the Metabolic Roles of Central and Peripheral Dopamine D2-Like Receptors A Bonifazi, MP Ellenberger, Z Farino, R Rais, J Mantilla-Rivas, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 1472-P: Dual Pancreatic Adrenergic and Dopaminergic Signaling as a Therapeutic Mechanism for Treatment of Dysglycemia by Bromocriptine D Aslanoglou, S Bertera, L Friggeri, MS Soto, J Lee, X Xue, R Logan, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
